This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
M.S Albert . (1997). The ageing brain: Normal and abnormal memory. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 352, 1703–1709.
D.F. Benson , D.E. Kuhl , R.A. Hawkins , M.E. Phelps , J.L. Cummings , & S.Y Tsai . (1983). The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Archives of Neurology, 40, 11–14.
K.M. Bradley , V.T. O’Sullivan , N.D. Soper , Z. Nagy , E.M. King , A.D. Smith , (2002). Cerebral perfusion in SPET correlated with Braak pathological stage in Alzheimer’s disease. Brain, 125, 1772–1781.
R.L Buckner . (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron, 44, 195–208.
H. Bushke , & P.A Fuld . (1974). Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology, 24, 1019–1025.
H Christensen . (2001). What cognitive changes can be expected with normal ageing? Australian and New Zealand Journal of Psychiatry, 35, 768–775.
M. Folstein , S. Folstein , & P McHugh . (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
J.D Gabrieli . (1996). Memory systems analyses of mnemonic disorders in aging and age-related disease. Proceedings of the National Academy of Sciences of the United States of America, 93, 13534–13540.
D. Head , A.Z. Snyder , L.E. Girton , J.C. Morris , & R.L Buckner . (2005). Frontal-hippocampal double dissociation between normal aging and Alzheimer’s disease. Cerebral Cortex, 15, 732–739.
W Jagust . (2004). Molecular neuroimaging in Alzheimer’s disease. NeuroRX, 1, 206–212.
K.A. Johnson , S.T. Mueller , T.M. Walshe , R.J. English , & B.L Holman . (1987). Cerebral perfusion imaging in Alzheimer’s disease: Use of single photon emission computed tomography and iofetamine hydrochloride I 123. Archives of Neurology, 44, 165–168.
W.E. Klunk , H. Engler , A. Nordberg , Y. Wang , G. Blomqvist , D.P. Holt , (2004). Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Annals of Neurology, 55, 306–309.
D. Knopman , L.L. Boland , T. Mosley , G. Howard , D. Liao , M. Szklo , (2001). Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology, 56, 42–48.
Y. Krausz , O. Bonne , M. Gorfine , H. Karger , B. Lerer , & R Chisin . (1998). Age related changes in brain perfusion of normal subjects detected by Tc-99m HMPAO SPECT. Neuroradiology, 40, 428–434.
J.A. Luchsinger , & R Mayeux . (2004). Cardiovascular risk factors and Alzheimer’s disease. Current Atherosclerosis Reports, 6, 261–266.
J.A. Luchsinger , C. Reitz , L.S. Honig , M.X. Tang , S. Shea , & R Mayeux . (2005). Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology, 65, 545–551.
J.J. McArdle , E. Ferrer-Caja , F. Hamagami , & R.W Woodcock . (2002). Comparative longitudinal multilevel structural analyses of the growth and decline of multiple intellectual abilities over the life-span. Developmental Psychology, 38, 115–142.
G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price , & E.M Stadlan . (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology, 34, 939–944.
S. Nagamachi , T. Nishikawa , S. Ono , M. Ageta , T. Matsuo , S. Jinnouchi , (1994). Regional cerebral blood flow in diabetic patients: Evaluation by N-isopropyl-123I-IMP with SPECT. Nuclear Medicine Communications, 15, 455–460.
F. Nobili , G. Rodriguez , S. Marenco , F. De Carli , M. Gambaro , C. Castello , (1993). Regional cerebral blood flow in chronic hypertension. A correlative study. Stroke, 24, 1148–1153.
R. Quirce , J.M. Carril , J.F. Jimenez-Bonilla , J.A. Amado , C. Gutierrez-Mendigucia , I. Banzo , (1997). Semiquantitative assessment of cerebral blood flow with 99mTc- HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. European Journal of Nuclear Medicine, 24, 1507–1513.
T.A Salthouse . (2004). What and when of cognitive aging. Current Directions in Psychological Science, 13, 140–144.
N. Scarmeas , C.G. Habeck , E. Zarahn , K.A. Anderson , A. Park , J. Hilton , (2004). Covariance PET patterns in early Alzheimer’s disease and subjects with cognitive impairment but no dementia: Utility in group discrimination and correlations with functional performance. Neuroimage, 23, 35–45.
T.G. Shaw , K.F. Mortel , J.S. Meyer , R.L. Rogers , J. Hardenberg , & M.M Cutaia . (1984). Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology, 34, 855–862.
E.M Tucker-Drob . (2009). Differentiation of cognitive abilities across the lifespan. Developmental Psychology, 45, 1097–1118.
N. Tzourio-Mazoyer , B. Landeau , D. Papathanassiou , F. Crivello , O. Etard , N. Delcroix , (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage, 15, 273–289.